Form 8-K - Current report:
SEC Accession No. 0000200406-23-000043
Filing Date
2023-04-18
Accepted
2023-04-18 07:29:50
Documents
19
Period of Report
2023-04-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20230418.htm   iXBRL 8-K 40266
2 EX-99.1 a2023q1exhibit991.htm EX-99.1 63116
3 EX-99.2 a2023q1exhibit992.htm EX-99.2 942204
4 EX-99.3 a2023q1exhibit993.htm EX-99.3 3697
9 overallresultsupdatedformat.jpg GRAPHIC 14665
10 updatedregionalsales.jpg GRAPHIC 12641
11 updatedsegmentsales.jpg GRAPHIC 17372
  Complete submission text file 0000200406-23-000043.txt   1351804

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20230418.xsd EX-101.SCH 3326
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20230418_def.xml EX-101.DEF 16756
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20230418_lab.xml EX-101.LAB 34197
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20230418_pre.xml EX-101.PRE 17558
13 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20230418_htm.xml XML 8902
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 23825494
SIC: 2834 Pharmaceutical Preparations